Recent News

By Category: Research

Taming microbes to combat antibiotic resistance

(EurekAlert) With antibiotic resistant infections on the rise and a scarce pipeline of novel drugs to combat them, researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) are pursuing entirely new approaches to meet the challenge of drug-resistant infections by taming microbes rather than killing them. Michael Yeaman, PhD, an  Read More »

Bavarian Nordic to Develop Biodefense Vaccine

(Global Biodefense) The Defense Threat Reduction Agency (DTRA) has selected a vaccine platform from Bavarian Nordic A/S for the development of a vaccine against two potential biological threats to national security – Burkholderia pseudomallei and Burkholderia mallei. Under this new contract Bavarian Nordic will design, generate and test recombinant vaccines against Burkholderia. If the contract  Read More »

Early warning system for epidemics

(EurekAlert) Cholera has been all but eradicated in Europe, but this bacterial, primarily waterborne disease still claims thousands of lives in Africa every year. Scientists are examining the effects various environmental factors have on cholera epidemics in Uganda. As part of this work, the Fraunhofer Institute of Optronics, System Technologies and Image Exploitation IOSB in  Read More »

Health security effort to boost global disease response

(The Dolphin) Top administration officials joined representatives from federal agencies and 26 nations to launch an international effort that will help to boost the global capacity to prevent, detect and respond to disease outbreaks, Feb. 13. At the Department of Health and Human Services headquarters, HHS Secretary Kathleen Sebelius and Lisa Monaco, assistant to the  Read More »

Fine-tuning salmonella-based vaccines

(Medical News Today) An innovative vaccine technology makes use of reengineered salmonella to deliver protective immunity. If such recombinant attenuated salmonella vaccines or RASVs can be perfected, they hold the promise of safe, lost-cost, orally administered defenses against viral, bacterial, fungal and parasitic infections.In a new study, lead author Karen Brenneman and her colleagues at  Read More »